Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1589 results found
2025 ∙ Qi, X.
A systematic review of global COVID-19 vaccine PPPs: drivers and barriers to governance alignment
All age groups COVID-19 Logistics Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ebrahimi, B. Kargar Jahromi, H. Shafiei Jahromi, N. Molayem, M.
A Systematic Review of Ocular Complications Following Different Types of Covid-19 Vaccines
Adults Older adults COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Kalantari, Y. Mirahmadi, S. M. S. Alilou, S. Sadeghi, S. Aryanian, Z. Jafarzadeh, A. Goodarzi, A.
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination
Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Thiyagarajan, G. Nagasubramanian, V. R. Ravichandran, S. L. Baskaran, P. Thangam, D. C. Sankaranarayanan, R. K. Undela, K. Sridevi, B. Pelluri, R. Gurram, P. C. Rajangam, J.
Acceptance and reluctance of COVID-19 vaccination among the general population: a systematic review and meta-analysis of cross-sectional studies
All age groups COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Min Htike, W. Y. Zhang, M. Wu, Z. Zhou, X. Lyu, S. Kam, Y. W.
Addressing Vaccine Hesitancy in College Students Post COVID-19 Pandemic: A Systematic Review Using COVID-19 as a Case Study
Adolescents Adults Older adults COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Coyne, B. M. Ito, D. Tariq, A. Lew, S. Q. Kopp, J. Vinales, P. C. Malik, F. Gipson, P. E. Nobakht, E.
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Tzang, C. C. Sheng, H. Kuo, V. F. Luo, C. A. Lin, T. A. Lee, Y. T. Huang, E. S. Wu, P. H. Tzang, B. S. Hsu, T. C.
Association between COVID-19 and New-Onset Autoimmune Diseases: Updated Systematic Review and Meta-Analysis of 97 Million Individuals
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Sadowski, J. Huk, J. Otulak, S. Zawilo, J. Klaudel, T. Roszak, M. Tenczynski, D. Buldak, R. J.
Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Maggi, S. Fulop, T. De Vita, E. Limongi, F. Pizzol, D. Di Gennaro, F. Veronese, N.
Association between vaccinations and risk of dementia: A systematic review and meta-analysis
Adults Older adults COVID-19 Herpes zoster Tetanus Diphtheria Pertussis Influenza Pneumococcal disease Poliomyelitis Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...